Biomarkers for Oncology
JH · Effective Oct 1, 2015
90 active Medicare policies list C79.63, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J15
7 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C79.63 |
|---|---|---|
| Cancer Antigen 125 Testing | Oct 1, 2026 | Covered |
| Cancer Antigen 19-9 Testing | Oct 1, 2026 | Covered |
| Carcinoembryonic Antigen Testing | Oct 1, 2026 | Covered |
| Hematopoietic Stem Cell Transplantation for Germ Cell Tumors | Jan 6, 2026 | Covered |
| Human Chorionic Gonadotropin Testing | Apr 15, 2026 | Covered |
| Outpatient Alpha-Fetoprotein Testing | Apr 15, 2026 |
J15 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Oct 1, 2015
JE · Effective Jul 5, 2016
JF · Effective Jul 5, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Jul 25, 2021
JE · Effective Jul 4, 2021
JF · Effective Jul 4, 2021
J5 · Effective Jul 25, 2021
J8 · Effective Jul 25, 2021
JJ · Effective Jul 25, 2021
JM · Effective Jul 25, 2021
J9 · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Sep 27, 2026
National · Effective Mar 5, 2026
J6 · Effective Oct 1, 2026
National · Effective Nov 16, 2023
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2024
National · Effective Feb 19, 2026
J5 · Effective Aug 27, 2026
National · Effective Jul 14, 2022
National · Effective Feb 19, 2026
National · Effective Nov 16, 2023
J5 · Effective Jul 30, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 1, 2025
J5 · Effective Jun 25, 2026
National · Effective Feb 19, 2026
National · Effective Oct 1, 2021
National · Effective Nov 22, 2023
National · Effective Feb 5, 2026
J5 · Effective Jul 27, 2023
National · Effective Jun 2, 2022
National · Effective Nov 16, 2023
National · Effective Feb 5, 2026
J5 · Effective May 28, 2026
National · Effective Oct 30, 2025
National · Effective Oct 1, 2026
National · Effective Jul 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
| Covered |
| Policy | Effective | Status of C79.63 |
|---|---|---|
| Transvaginal Ultrasonography | Aug 8, 2023 | Covered |